electroCore (ECOR) Cash from Financing Activities (2017 - 2026)
electroCore's (ECOR) quarterly Cash from Financing Activities came in at $230000.0 in Q1 2026, up 27.78% year-on-year from $180000.0 in Q1 2025, and up 675.0% quarter-over-quarter from -$40000.0 in Q4 2025.
electroCore (ECOR) Cash from Financing Activities (2017 - 2026) Analysis & Trends
electroCore's Cash from Financing Activities history runs 8 years deep, the most recent figure standing at $230000.0 for Q1 2026.
- On a quarterly basis, Cash from Financing Activities rose 27.78% year-over-year to $230000.0 in Q1 2026; TTM through Mar 2026 was $7.7 million, a 1438.48% increase from a year earlier, with the FY2025 full-year figure at $7.6 million, down 9.62% from the prior year.
- Cash from Financing Activities rose to $230000.0 in Q1 2026 per ECOR's latest filing, from -$40000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $7.5 million in Q3 2025 and bottomed at -$52000.0 in Q3 2024.
- The 3-year median for Cash from Financing Activities is $180000.0 (2025), against an average of $1.2 million.
- Biggest YoY gain for Cash from Financing Activities was 14492.31% in 2025; the steepest drop was 110.78% in 2025.
- Year by year, Cash from Financing Activities stood at $371000.0 in 2024, then slumped by 110.78% to -$40000.0 in 2025, then soared by 675.0% to $230000.0 in 2026.
- Per Business Quant, the three latest ECOR Cash from Financing Activities figures stand at $230000.0 (Q1 2026), -$40000.0 (Q4 2025), and $7.5 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -25.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -26.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | electroCore | 56,941.08 | -8.77 Mn | 8.36 Mn | 230,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 230,000.00 |
| Mar 31, 2026 | 230,000.00 |
| Dec 31, 2025 | -40,000.00 |
| Dec 31, 2025 | -40,000.00 |
| Sep 30, 2025 | 7.48 Mn |
| Sep 30, 2025 | 7.48 Mn |
| Jun 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Mar 31, 2025 | 180,000.00 |
| Mar 31, 2025 | 180,000.00 |
| Dec 31, 2024 | 371,000.00 |
| Dec 31, 2024 | 371,000.00 |
| Sep 30, 2024 | -52,000.00 |
| Sep 30, 2024 | -52,000.00 |
| Dec 31, 2021 | -3,000.00 |
| Dec 31, 2021 | -3,000.00 |
| Sep 30, 2021 | 18.77 Mn |
| Sep 30, 2021 | 18.77 Mn |
| Mar 31, 2021 | 6.92 Mn |
| Mar 31, 2021 | 6.92 Mn |